Rapport Therapeutics to Present at Morgan Stanley Healthcare Conference and TD Cowen Neuropsychiatry Summit

BOSTON and SAN DIEGO, Aug. 29, 2024 - Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company, announced that its management will be presenting at two forthcoming investor conferences. The first event is the Morgan Stanley 22nd Annual Global Healthcare Conference in New York City on September 5, 2024, at 4:50 pm ET. The second event is TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit, which will be held virtually on September 26, 2024, at 11:40 am ET. Those interested can access a live and recorded webcast of the Morgan Stanley Conference fireside chat on the “Investors” section of the company’s website.

Rapport Therapeutics focuses on the discovery and development of groundbreaking small molecule medicines for patients with central nervous system (CNS) disorders. The company’s founders have made significant discoveries related to receptor associated proteins (RAPs) in the brain, which serve as the foundation for Rapport’s RAP technology platform. This platform facilitates a unique approach to creating precision small molecule product candidates aimed at overcoming many of the limitations found in traditional neurology drug discovery.

The company's precision neuroscience pipeline includes its leading clinical program, RAP-219. RAP-219 is designed for neuroanatomical specificity through selective targeting of a RAP found only in specific regions of the brain. Currently, RAP-219 is being tested in clinical trials for focal epilepsy, peripheral neuropathic pain, and bipolar disorder. In addition to RAP-219, Rapport Therapeutics is advancing several other programs in preclinical and late-stage discovery phases. These programs target CNS disorders such as chronic pain and hearing disorders.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!